Theradiag
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
ALTER | PA
Overview
Corporate Details
- ISIN(s):
- FR00140069U4
- LEI:
- 969500CDG241WHIFL611
- Country:
- France
- Address:
- 14 RUE AMBROISE CROIZAT, 77183 CROISSY-BEAUBOURG
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Theradiag is a company specializing in the development, manufacturing, and marketing of in-vitro diagnostics (IVD) and theranostics tests. With over 30 years of experience, the company is a leader in biotherapy monitoring, providing innovative solutions that help clinicians measure the efficacy of treatments and enhance patient management. Its core offerings include the LISA-TRACKER® range of kits, primarily focused on autoimmune diseases and oncology. Theradiag leverages its expertise to develop diagnostic tools for personalized medicine, expanding its portfolio to assist in monitoring biotherapies across various treatment areas.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Theradiag and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-12-20 13:02 |
Share Issue/Capital Change
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 265.7 KB | |
| 2023-12-15 18:00 |
Post-Annual General Meeting Information
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 304.7 KB | |
| 2023-12-07 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 169.5 KB | |
| 2023-10-11 17:45 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 300.2 KB | |
| 2023-10-11 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 302.7 KB | |
| 2023-09-29 18:00 |
M&A Activity
Informations privilégiées / Autres communiqués
|
French | 328.5 KB | |
| 2023-09-18 07:30 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 249.0 KB | |
| 2023-09-18 07:30 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 270.0 KB | |
| 2023-07-17 07:30 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 298.0 KB | |
| 2023-07-17 07:30 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 286.1 KB | |
| 2023-07-05 17:45 |
Business and Financial Review
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 271.7 KB | |
| 2023-07-04 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 175.2 KB | |
| 2023-06-01 17:45 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 206.2 KB | |
| 2023-05-09 17:45 |
Report Publication Announcement
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 174.7 KB | |
| 2023-04-27 17:45 |
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 6.0 MB |
Automate Your Workflow. Get a real-time feed of all Theradiag filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Theradiag via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
